Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

11.1%

1 terminated/withdrawn out of 9 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

6(85.7%)

Phase 4

1(14.3%)

7Total

N/A(6)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT06410352Phase 4Recruiting

Effectiveness of Weight Loss Methods on Lifespan for Metabolic Syndrome

Role: lead

NCT06721182Not ApplicableNot Yet Recruiting

Effectiveness of REBOA in Reducing Blood Loss During Cesarean Section in Patients with PAS

Role: collaborator

NCT05654974Completed

Sexual Habits Affect Penis Size in Adulthood

Role: lead

NCT06296732Recruiting

Abdominal Neuroblastoma Laparoscopic Surgery Risk Factors Stratification

Role: collaborator

NCT05635539Not ApplicableCompleted

Weight Loss in Patients With COVID-19 and Influenza in Comorbidity With NCDs: a Pilot Prospective Clinical Trial

Role: lead

NCT04762849Not ApplicableWithdrawn

A Banded One Anastomosis Gastric Bypass With Use Shape-memory Ring Versus Non-banded One Anastomosis Gastric Bypass

Role: lead

NCT05645419Not ApplicableUnknown

Chronoprognosis of Myocardial Infarction in Patients With Type 2 Diabetes Mellitus

Role: lead

NCT03667469Not ApplicableCompleted

Study of the Life Expectancy of Patients With Metabolic Syndrome After Weight Loss:

Role: lead

NCT03454867Not ApplicableCompleted

Hemofiltration in Acute Ischemic Stroke

Role: lead

All 9 trials loaded